Penny Stocks Watch List - Rapid Fire Marketing Inc (PINK:RFMK), JOURNAL RADIOLOGY in (OTC:JRRD), Advaxis, Inc. (OTC:ADXS)

New York, NY -- (SBWIRE) -- 02/15/2013 -- StockRunway.com brings some bearish movers of the day, which remained most volatile for the day. A comprehencive trend analysis report of Rapid Fire Marketing Inc (PINK:RFMK), JOURNAL RADIOLOGY IN (OTC:JRRD) and Advaxis, Inc. (OTC:ADXS) is here to ease investors to watch out the stock more deeply.

Today’s first pick is Rapid Fire Marketing Inc (PINK:RFMK) moved down -7.89% to close at $0.0035, the stock exchanged quite well during last trading session as it gained a total trading volume of 110.47 million shares almost doubled from its average trading capacity of 55.56 million shares.

Will RFMK Get Buyers Even After The Recent Rally? Find Out Here

Rapid Fire Marketing Inc (RFMK)’s total outstanding shares are 1.13 billion while its total market capitalization is 3.96 million. During last 6 months of trading activity the shares moved quite well and scored 288.89% while in last one month of trading it soared more than 94%.

JOURNAL RADIOLOGY IN (OTC:JRRD) reported that it has accomplished its latest international trip in Europe with more success. Time duration of the trip was 10 days during which it go through Germany, Austria, Belgium and Netherlands and accomplished several meetings with both immediate sales and long term prospective. JOURNAL RADIOLOGY IN (JRRD) is a world provider of interactive digital network tools, which promises to enlarge its services in 2013 and onwards.

Why Should Investors Buy JRRD After the Recent Fall? Just Go Here and Find Out

JRRD remained among day losers as it slid -10.00%. Overall trading volume of the stock was 6.80 million shares 5 times bigger from the average trading volume 1.04 million shares. Its closing price for the day was $0.0018. In its last 5 trading sessions the stock heaved up and scored 5.88%.

Another stock in news is Advaxis, Inc. (OTC:ADXS), which reported a decline of -13.04% for the day after opening its shares at $0.09. After scoring a volume of 6.25 million shares, stock closed at $0.0800, its average trading volume is 6.53 million shares. Stock’s beta value stood at 1.85 points and its total market capitalization is 31.38 million.

Has ADXS Found The Bottom And Ready To Gain Momentum? Find Out Here

In an interview, Tom Moore Chairman and CEO of the company deliberated the business model, immunotherapy pipeline, targeted markets, and recent developments of the company. In the interview he also discussed the background information on the management team and short-term goals of the Company.

About StockRunway.com
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.

Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!

This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.